Walgreens Ebitda from 2010 to 2024

WBA Stock  USD 8.30  0.06  0.73%   
Walgreens Boots' EBITDA is decreasing over the years with slightly volatile fluctuation. Overall, EBITDA is projected to go to about -10.7 B this year. From 2010 to 2024 Walgreens Boots EBITDA quarterly data regression line had arithmetic mean of  3,256,486,667 and r-squared of  0.26. View All Fundamentals
 
EBITDA  
First Reported
1985-08-31
Previous Quarter
715 M
Current Value
-244 M
Quarterly Volatility
1.5 B
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Walgreens Boots financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Walgreens Boots' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 B, Interest Expense of 506.1 M or Total Revenue of 155 B, as well as many indicators such as Price To Sales Ratio of 0.0514, Dividend Yield of 0.17 or PTB Ratio of 0.73. Walgreens financial statements analysis is a perfect complement when working with Walgreens Boots Valuation or Volatility modules.
  
Check out the analysis of Walgreens Boots Correlation against competitors.

Latest Walgreens Boots' Ebitda Growth Pattern

Below is the plot of the Ebitda of Walgreens Boots Alliance over the last few years. It is Walgreens Boots' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Walgreens Boots' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Walgreens Ebitda Regression Statistics

Arithmetic Mean3,256,486,667
Geometric Mean4,956,442,510
Coefficient Of Variation188.94
Mean Deviation4,206,821,333
Median5,029,000,000
Standard Deviation6,152,671,318
Sample Variance37855364.3T
Range19.6B
R-Value(0.51)
Mean Square Error30346103.8T
R-Squared0.26
Significance0.05
Slope(695,587,500)
Total Sum of Squares529975100.8T

Walgreens Ebitda History

2024-10.7 B
2023-11.3 B
20223.5 B
2021B
2020B
20193.3 B
20187.3 B

About Walgreens Boots Financial Statements

Walgreens Boots stakeholders use historical fundamental indicators, such as Walgreens Boots' Ebitda, to determine how well the company is positioned to perform in the future. Although Walgreens Boots investors may analyze each financial statement separately, they are all interrelated. For example, changes in Walgreens Boots' assets and liabilities are reflected in the revenues and expenses on Walgreens Boots' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Walgreens Boots Alliance. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-11.3 B-10.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:
Check out the analysis of Walgreens Boots Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.915
Dividend Share
1.23
Earnings Share
(10.01)
Revenue Per Share
171.079
Quarterly Revenue Growth
0.06
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.